肿瘤坏死因子：帕金森病模型中神经毒性和神经退行性变的关键神经炎症介质。 - Suppr

Suppr

超能文献

TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of Parkinson's disease.

作者信息

McCoy Melissa K, Ruhn Kelly A, Blesch Armin, Tansey Malú G

机构信息

Department of Physiology, UT Southwestern Medical Center, Dallas, TX 75390, USA.

出版信息

Adv Exp Med Biol. 2011;691:539-40. doi: 10.1007/978-1-4419-6612-4_56.

DOI:10.1007/978-1-4419-6612-4_56

PMID:21153359

Abstract

摘要

相似文献

TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of Parkinson's disease.

Adv Exp Med Biol. 2011;691:539-40. doi: 10.1007/978-1-4419-6612-4_56.

The functional anatomy of noradrenergic neurons in Parkinson's disease.

Funct Neurol. 1999 Apr-Jun;14(2):97-109.

NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease.

Eur J Pharmacol. 2025 Sep 5;1002:177733. doi: 10.1016/j.ejphar.2025.177733. Epub 2025 May 28.

Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.

J Neurosci. 2006 Sep 13;26(37):9365-75. doi: 10.1523/JNEUROSCI.1504-06.2006.

Gene delivery of SUMO1-derived peptide rescues neuronal degeneration and motor deficits in a mouse model of Parkinson's disease.

Mol Ther. 2025 Jul 2;33(7):3056-3072. doi: 10.1016/j.ymthe.2025.04.005. Epub 2025 Apr 5.

Unravelling the Proteinopathic Engagement of α-Synuclein, Tau, and Amyloid Beta in Parkinson's Disease: Mitochondrial Collapse as a Pivotal Driver of Neurodegeneration.

Neurochem Res. 2025 Apr 16;50(3):145. doi: 10.1007/s11064-025-04399-7.

The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies.

Neurochem Int. 2022 Sep;158:105376. doi: 10.1016/j.neuint.2022.105376. Epub 2022 Jun 3.

Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.

Int J Mol Sci. 2019 Mar 27;20(7):1538. doi: 10.3390/ijms20071538.

The mammalian striatum and neurotoxic injury.

Brain Pathol. 2002 Oct;12(4):482-7. doi: 10.1111/j.1750-3639.2002.tb00466.x.

Mechanism of cell death in experimental models of Parkinson's disease.

Funct Neurol. 2000 Oct-Dec;15(4):229-37.

引用本文的文献

The synergetic effect of edaravone and scutellarin in the MPP(+)-induced cell model of Parkinson's disease.

Histol Histopathol. 2025 Sep;40(9):1457-1466. doi: 10.14670/HH-18-874. Epub 2025 Jan 16.

Neurodegeneration and demyelination in multiple sclerosis.

Neuron. 2024 Oct 9;112(19):3231-3251. doi: 10.1016/j.neuron.2024.05.025. Epub 2024 Jun 17.

The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease.

Cell Commun Signal. 2024 Jan 12;22(1):31. doi: 10.1186/s12964-023-01402-y.

Fluoxetine Protects Retinal Ischemic Damage in Mice.

Pharmaceutics. 2023 Apr 29;15(5):1370. doi: 10.3390/pharmaceutics15051370.

Inflammation and immune dysfunction in Parkinson disease.

Nat Rev Immunol. 2022 Nov;22(11):657-673. doi: 10.1038/s41577-022-00684-6. Epub 2022 Mar 4.

Hyperkeratinization and Proinflammatory Cytokine Expression in Meibomian Glands Induced by Staphylococcus aureus.

Invest Ophthalmol Vis Sci. 2021 Oct 4;62(13):11. doi: 10.1167/iovs.62.13.11.

Cannabidiol modulation of oxidative stress and signalling.

Neuronal Signal. 2021 Aug 24;5(3):NS20200080. doi: 10.1042/NS20200080. eCollection 2021 Sep.

Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology.

Acta Neuropathol Commun. 2021 Aug 19;9(1):139. doi: 10.1186/s40478-021-01240-4.

P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD.

Front Aging Neurosci. 2020 Nov 4;12:580068. doi: 10.3389/fnagi.2020.580068. eCollection 2020.

Marine-Derived Reduces Tumor Size and Ameliorates Inflammation in an Erlich Mice Model.

Mar Drugs. 2020 Oct 29;18(11):541. doi: 10.3390/md18110541.

本文引用的文献

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

Neurobiol Dis. 2010 Mar;37(3):510-8. doi: 10.1016/j.nbd.2009.11.004. Epub 2009 Nov 10.

Neuroinflammation in Parkinson's disease.

J Neuroimmune Pharmacol. 2009 Dec;4(4):419-29. doi: 10.1007/s11481-009-9176-0. Epub 2009 Oct 10.

NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies.

Drugs Aging. 2009;26(9):769-79. doi: 10.2165/11316780-000000000-00000.

Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats.

Mol Ther. 2008 Sep;16(9):1572-9. doi: 10.1038/mt.2008.146. Epub 2008 Jul 15.

Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.

J Neurosci. 2006 Sep 13;26(37):9365-75. doi: 10.1523/JNEUROSCI.1504-06.2006.

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.

Ann Neurol. 2005 Dec;58(6):963-7. doi: 10.1002/ana.20682.

Inactivation of TNF signaling by rationally designed dominant-negative TNF variants.

Science. 2003 Sep 26;301(5641):1895-8. doi: 10.1126/science.1081297.

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.

Arch Neurol. 2003 Aug;60(8):1059-64. doi: 10.1001/archneur.60.8.1059.

Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease.

Neurosci Lett. 2001 Sep 21;311(1):1-4. doi: 10.1016/s0304-3940(01)02111-5.

Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons.

Exp Neurol. 2001 Jun;169(2):219-30. doi: 10.1006/exnr.2001.7688.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验